Trials / Completed
CompletedNCT02756351
A Efficacy and Safety Study of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization
A Double-blinded Randomized Clinical Pilot Trial of Nasal Prongs With Proprietary Surface Coating Aiming to Reduce Bacterial Colonization
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- CytaCoat AB · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study is a first step in establishing the safety and efficacy of the CytaCoat technology when applied to a medical device such as a nasal prong and the clinical data generated will serve as a basis for continuous studies in clinically significant settings such as the neonatal care units.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CytaCoat Nasal Prong | |
| DEVICE | Inspiration Healthcare Inspire nCPAP Nasal Prong |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2016-06-01
- Completion
- 2016-07-01
- First posted
- 2016-04-29
- Last updated
- 2017-02-01
- Results posted
- 2017-02-01
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02756351. Inclusion in this directory is not an endorsement.